-+ 0.00%
-+ 0.00%
-+ 0.00%

Nasus Pharma Appoints Nir Sassi as Chief Financial Officer

PUBT·11/16/2026 13:00:20
Listen to the news
Nasus Pharma Appoints Nir Sassi as Chief Financial Officer
  • Nasus Pharma appointed Nir Sassi chief financial officer, effective November 11, 2026.
  • Sassi most recently served as CFO of Indaptus Therapeutics; he previously held the same role at Intec Pharma.
  • He brings nearly 25 years of experience in public company finance, capital markets and biopharmaceutical operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nasus Pharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160800PRIMZONEFULLFEED9877920) on November 16, 2026, and is solely responsible for the information contained therein.